[1] L.T. McGrath, R. Patrick, P. Mallon, L. Dowey, B. Silke, W. Norwood, S. Elborn, Breath isoprene during acute respiratory exacerbation in cystic fibrosis, Eur. Respir. J. 16 (2000) 1065–1069.
[2] J.K. Schubert, W.P.E. Müller, A. Benzing, K. Geiger, Application of a new method for analysis of exhaled gas in critically ill patients, Intensive Care Med. 24 (1998) 415–421. https://doi.org/10.1007/s001340050589.
[3] S. Mendis, P.A. Sobotka, D.E. Euler, Expired Hydrocarbons in Patients with Acute Myocardial Infarction, Free Radic. Res. 23 (1995) 117–122. https://doi.org/10.3109/10715769509064026.
[4] T. Karl, P. Prazeller, D. Mayr, A. Jordan, J. Rieder, R. Fall, W. Lindinger, Human breath isoprene and its relation to blood cholesterol levels: new measurements and modeling, J. Appl. Physiol. 91 (2001) 762–770. https://doi.org/10.1152/jappl.2001.91.2.762.
[5] F. Pabst, W. Miekisch, P. Fuchs, S. Kischkel, J.K. Schubert, Monitoring of oxidative and metabolic stress during cardiac surgery by means of breath biomarkers: an observational study, J. Cardiothorac. Surg. 2 (2007) 37. https://doi.org/10.1186/1749-8090-2-37.
[6] D. Fuchs, H. Jamnig, P. Heininger, M. Klieber, S. Schroecksnadel, M. Fiegl, M. Hackl, H. Denz, A. Amann, Decline of exhaled isoprene in lung cancer patients correlates with immune activation, J. Breath Res. 6 (2012) 027101. https://doi.org/10.1088/1752-7155/6/2/027101.
[7] D. Poli, P. Carbognani, M. Corradi, M. Goldoni, O. Acampa, B. Balbi, L. Bianchi, M. Rusca, A. Mutti, Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study, Respir. Res. 6 (2005) 71. https://doi.org/10.1186/1465-9921-6-71.
[8] N. Alkhouri, T. Singh, E. Alsabbagh, J. Guirguis, T. Chami, I. Hanouneh, D. Grove, R. Lopez, R. Dweik, Isoprene in the Exhaled Breath is a Novel Biomarker for Advanced Fibrosis in Patients with Chronic Liver Disease: A Pilot Study, Clin. Transl. Gastroenterol. 6 (2015) e112. https://doi.org/10.1038/ctg.2015.40.
[9] R. Salerno-Kennedy, K.D. Cashman, Potential applications of breath isoprene as a biomarker in modern medicine: a concise overview, Wien. Klin. Wochenschr. 117 (2005) 180–186. https://doi.org/10.1007/s00508-005-0336-9.
[10] J. King, A. Kupferthaler, K. Unterkofler, H. Koc, S. Teschl, G. Teschl, W. Miekisch, J. Schubert, H. Hinterhuber, A. Amann, Isoprene and acetone concentration profiles during exercise on an ergometer, J. Breath Res. 3 (2009) 027006. https://doi.org/10.1088/1752-7155/3/2/027006.
[11] J. King, A. Kupferthaler, B. Frauscher, H. Hackner, K. Unterkofler, G. Teschl, H. Hinterhuber, A. Amann, B. Högl, Measurement of endogenous acetone and isoprene in exhaled breath during sleep, Physiol. Meas. 33 (2012) 413–428. https://doi.org/10.1088/0967-3334/33/3/413.
[12] P. Sukul, P. Trefz, S. Kamysek, J.K. Schubert, W. Miekisch, Instant effects of changing body positions on compositions of exhaled breath, J. Breath Res. 9 (2015) 047105. https://doi.org/10.1088/1752-7155/9/4/047105.
[13] P. Sukul, J.K. Schubert, P. Oertel, S. Kamysek, K. Taunk, P. Trefz, W. Miekisch, FEV manoeuvre induced changes in breath VOC compositions: an unconventional view on lung function tests, Sci. Rep. 6 (2016) 28029. https://doi.org/10.1038/srep28029.
[14] P. Sukul, J.K. Schubert, P. Trefz, W. Miekisch, Natural menstrual rhythm and oral contraception diversely affect exhaled breath compositions, Sci. Rep. 8 (2018) 10838. https://doi.org/10.1038/s41598-018-29221-z.
[15] B.G. Stone, T.J. Besse, W.C. Duane, C.D. Evans, E.G. DeMaster, Effect of regulating cholesterol biosynthesis on breath isoprene excretion in men, Lipids. 28 (1993) 705–708.
[16] B. Buszewski, M. Kesy, T. Ligor, A. Amann, Human exhaled air analytics: biomarkers of diseases, Biomed. Chromatogr. BMC. 21 (2007) 553–566. https://doi.org/10.1002/bmc.835.
[17] N.M.F.S.A. Cerqueira, E.F. Oliveira, D.S. Gesto, D. Santos-Martins, C. Moreira, H.N. Moorthy, M.J. Ramos, P.A. Fernandes, Cholesterol Biosynthesis: A Mechanistic Overview, Biochemistry. 55 (2016) 5483–5506. https://doi.org/10.1021/acs.biochem.6b00342.
[18] G. Hoffmann, K.M. Gibson, I.K. Brandt, P.I. Bader, R.S. Wappner, L. Sweetman, Mevalonic Aciduria — An Inborn Error of Cholesterol and Nonsterol Isoprene Biosynthesis, N. Engl. J. Med. 314 (1986) 1610–1614. https://doi.org/10.1056/NEJM198606193142504.
[19] D. Haas, G.F. Hoffmann, Mevalonate Kinase Deficiency and Autoinflammatory Disorders, Http://Dx.Doi.Org/10.1056/NEJMp078083. (2009). https://doi.org/10.1056/NEJMp078083.
[20] B. Neven, V. Valayannopoulos, P. Quartier, S. Blanche, A.-M. Prieur, M. Debré, M.-O. Rolland, D. Rabier, L. Cuisset, M. Cavazzana-Calvo, P. de Lonlay, A. Fischer, Allogeneic Bone Marrow Transplantation in Mevalonic Aciduria, N. Engl. J. Med. 356 (2007) 2700–2703. https://doi.org/10.1056/NEJMoa070715.
[21] J. King, P. Mochalski, K. Unterkofler, G. Teschl, M. Klieber, M. Stein, A. Amann, M. Baumann, Breath isoprene: Muscle dystrophy patients support the concept of a pool of isoprene in the periphery of the human body, Biochem. Biophys. Res. Commun. 423 (2012) 526–530. https://doi.org/10.1016/j.bbrc.2012.05.159.
[22] P. Trefz, J. Obermeier, R. Lehbrink, J.K. Schubert, W. Miekisch, D.-C. Fischer, Exhaled volatile substances in children suffering from type 1 diabetes mellitus: results from a cross-sectional study, Sci. Rep. 9 (2019) 15707. https://doi.org/10.1038/s41598-019-52165-x.
[23] P. Trefz, S.C. Schmidt, P. Sukul, J.K. Schubert, W. Miekisch, D.-C. Fischer, Non-Invasive Assessment of Metabolic Adaptation in Paediatric Patients Suffering from Type 1 Diabetes Mellitus, J. Clin. Med. 8 (2019). https://doi.org/10.3390/jcm8111797.
[24] I. Kushch, B. Arendacká, S. Stolc, P. Mochalski, W. Filipiak, K. Schwarz, L. Schwentner, A. Schmid, A. Dzien, M. Lechleitner, V. Witkovský, W. Miekisch, J. Schubert, K. Unterkofler, A. Amann, Breath isoprene--aspects of normal physiology related to age, gender and cholesterol profile as determined in a proton transfer reaction mass spectrometry study, Clin. Chem. Lab. Med. 46 (2008) 1011–1018. https://doi.org/10.1515/CCLM.2008.181.
[25] P. Lirk, F. Bodrogi, H. Raifer, K. Greiner, H. Ulmer, J. Rieder, Elective haemodialysis increases exhaled isoprene, Nephrol. Dial. Transplant. 18 (2003) 937–941. https://doi.org/10.1093/ndt/gfg049.
[26] M.L. T, P. Robin, S. Bernard, Breath isoprene in patients with heart failure, Eur. J. Heart Fail. 3 (2001) 423–427. https://doi.org/10.1016/S1388-9842(01)00128-3.
[27] T. Kuzuyama, H. Seto, Diversity of the biosynthesis of the isoprene units, Nat. Prod. Rep. 20 (2003) 171–183. https://doi.org/10.1039/B109860H.
[28] E.S. Deneris, R.A. Stein, J.F. Mead, Invitro biosynthesis of isoprene from mevalonate utilizing a rat liver cytosolic fraction, Biochem. Biophys. Res. Commun. 123 (1984) 691–696. https://doi.org/10.1016/0006-291X(84)90284-5.
[29] J.E. Metherall, K. Waugh, H. Li, Progesterone Inhibits Cholesterol Biosynthesis in Cultured Cells ACCUMULATION OF CHOLESTEROL PRECURSORS, J. Biol. Chem. 271 (1996) 2627–2633. https://doi.org/10.1074/jbc.271.5.2627.
[30] S.L. Mumford, S. Dasharathy, A.Z. Pollack, E.F. Schisterman, Variations in lipid levels according to menstrual cycle phase: clinical implications, Clin. Lipidol. 6 (2011) 225–234. https://doi.org/10.2217/clp.11.9.
[31] P. Sukul, P. Oertel, S. Kamysek, P. Trefz, Oral or nasal breathing? Real-time effects of switching sampling route onto exhaled VOC concentrations, J. Breath Res. 11 (2017) 027101. https://doi.org/10.1088/1752-7163/aa6368.
[32] P. Sukul, J.K. Schubert, S. Kamysek, P. Trefz, W. Miekisch, Applied upper-airway resistance instantly affects breath components: a unique insight into pulmonary medicine, J. Breath Res. 11 (2017) 047108. https://doi.org/10.1088/1752-7163/aa8d86.
[33] P. Sukul, J.K. Schubert, K. Zanaty, P. Trefz, A. Sinha, S. Kamysek, W. Miekisch, Exhaled breath compositions under varying respiratory rhythms reflects ventilatory variations: translating breathomics towards respiratory medicine, Sci. Rep. 10 (2020) 14109. https://doi.org/10.1038/s41598-020-70993-0.
[34] P. Trefz, M. Schmidt, P. Oertel, J. Obermeier, B. Brock, S. Kamysek, J. Dunkl, R. Zimmermann, J.K. Schubert, W. Miekisch, Continuous real time breath gas monitoring in the clinical environment by proton-transfer-reaction-time-of-flight-mass spectrometry, Anal. Chem. 85 (2013) 10321–10329. https://doi.org/10.1021/ac402298v.
[35] A. Richter, S. Sender, A. Lenz, R. Schwarz, B. Hinz, G. Knuebel, A. Sekora, H. Murua Escobar, C. Junghanss, C. Roolf, Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo, BMC Cancer. 20 (2020) 184. https://doi.org/10.1186/s12885-020-6650-9.
[36] N. Nelson, V. Lagesson, A.R. Nosratabadi, J. Ludvigsson, C. Tagesson, Exhaled Isoprene and Acetone in Newborn Infants and in Children with Diabetes Mellitus, Pediatr. Res. 44 (1998) 363–367. https://doi.org/10.1203/00006450-199809000-00016.
[37] P. Sukul, P. Trefz, J.K. Schubert, W. Miekisch, Immediate effects of breath holding maneuvers onto composition of exhaled breath, J. Breath Res. 8 (2014) 037102. https://doi.org/10.1088/1752-7155/8/3/037102.
[38] Ä. Bartels, K. O’Donoghue, Cholesterol in pregnancy: a review of knowns and unknowns, Obstet. Med. 4 (2011) 147–151. https://doi.org/10.1258/om.2011.110003.
[39] T.D. Sharkey, Isoprene synthesis by plants and animals, Endeavour. 20 (1996) 74–78. https://doi.org/10.1016/0160-9327(96)10014-4.
[40] T.D. Sharkey, S. Yeh, A.E. Wiberley, T.G. Falbel, D. Gong, D.E. Fernandez, Evolution of the Isoprene Biosynthetic Pathway in Kudzu, Plant Physiol. 137 (2005) 700–712. https://doi.org/10.1104/pp.104.054445.
[41] P.C. Harley, R.K. Monson, M.T. Lerdau, Ecological and evolutionary aspects of isoprene emission from plants, Oecologia. 118 (1999) 109–123. https://doi.org/10.1007/s004420050709.
[42] R.L. Melnick, R.C. Sills, J.H. Roycroft, B.J. Chou, H.A. Ragan, R.A. Miller, Inhalation toxicity and carcinogenicity of isoprene in rats and mice: comparisons with 1,3-butadiene, Toxicology. 113 (1996) 247–252. https://doi.org/10.1016/0300-483X(96)03453-1.
[43] National Toxicology Program, NTP Toxicology and Carcinogenesis Studies of Isoprene (CAS No. 78-79-5) in F344/N Rats (Inhalation Studies), Natl. Toxicol. Program Tech. Rep. Ser. 486 (1999) 1–176.
[44] D. Anderson, Genetic and reproductive toxicity of butadiene and isoprene, Chem. Biol. Interact. 135–136 (2001) 65–80. https://doi.org/10.1016/s0009-2797(01)00171-5.
[45] R. van der Burgh, N.M. ter Haar, M.L. Boes, J. Frenkel, Mevalonate kinase deficiency, a metabolic autoinflammatory disease, Clin. Immunol. 147 (2013) 197–206. https://doi.org/10.1016/j.clim.2012.09.011.
[46] S. Zhang, Natural history of mevalonate kinase deficiency: a literature review, Pediatr. Rheumatol. Online J. 14 (2016). https://doi.org/10.1186/s12969-016-0091-7.